Automatic Injector Porous Member Mixing
Solution Overview
Problem
Existing automatic injectors are inefficient in delivering small, precise amounts of therapeutic agents, requiring manual premixing and additional space for dry compartments, which is costly and time-consuming, especially in emergency situations.
Innovation Solution
A compact automatic injector design featuring a thin or flat porous member that carries a small, precise amount of therapeutic agent, eliminating the need for a second dry compartment and allowing for rapid mixing without manual intervention.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stability of the object's composition
If a dry compartment is added to store solid therapeutic agent, then the therapeutic agent can be stored in solid form for long-term stability, but the device size and complexity increase
Solution Approach 1:
The patent combines the solid therapeutic agent storage function directly into the needle assembly by integrating a porous member onto the needle or within the hub, eliminating the need for a separate dry compartment. This merging of functions reduces device complexity while maintaining the ability to store stable solid therapeutic agents.
Solution Approach 2:
The porous member carrying the solid therapeutic agent is nested within or attached to the needle assembly structure, which itself is nested within the liquid-filled cartridge. This nested arrangement allows compact integration of multiple storage modes without increasing overall device size or complexity.
2Stability of the object's composition
If manual shaking is required to mix solid and liquid components, then dissolution can be expedited, but the administration time increases
Solution Approach 1:
The device is designed to automatically mix the solid therapeutic agent with the liquid component through the mechanical action of injection itself. As the plunger pushes liquid through the needle assembly containing the porous member, the pressure differential and flow dynamics automatically dissolve and carry the solid agent, eliminating the need for manual shaking by the user.
Solution Approach 2:
The solid therapeutic agent is pre-loaded onto the porous member in a position where it will be automatically contacted and dissolved by the liquid flow during the injection process. The device is prepared in advance with the solid agent positioned for immediate dissolution upon activation, eliminating delays during administration.
3Stability of the object's composition
If a large dry chamber is used to ensure effective mixing, then mixing can be effective, but the amount of therapeutic agent required increases
Solution Approach 1:
Instead of requiring a large chamber for mixing, the invention concentrates the mixing function at the local level where the liquid flow directly contacts the solid therapeutic agent on the porous member. This localized mixing approach achieves effective dissolution and mixing in a minimal space, allowing precise delivery of small therapeutic agent doses without waste.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables rapid, cost-effective delivery of small therapeutic agent doses without manual premixing, reducing device size and increasing efficiency in emergency situations.
Implementation Method 1
a thin or flat porous member carrying the small, precise amount of the therapeutic agent
Data Source
Figure 1
Figure 2
Figure 3
AI summary
A drug delivery system includes an automatic injector that can deliver a small, precise amount of a therapeutic agent. The automatic injector includes a chamber for containing a liquid component and a thin porous member that carries thereon and/or therein the small, precise amount of therapeutic agent. Upon activation of the automatic injector, a flow path opens from the chamber through the porous member, enabling the liquid component to rapidly mix with the therapeutic agent before being injected.
